Effect of probiotics on blood lipid level

Phase 3

Recruiting

• Conditions: Condition 1: MILD HYPERCHOLESTEROLEMIA ( total cholesterol 220-280 mg/dl). Condition 2: blood glucose level as beside finding.; Pure hypercholesterolemia; Other abnormal glucose; E78.0; R73.09

• Registration Number: IRCT20240512061765N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

•Adults aged 18-65 years
•Individuals with mild hypercholesterolemia(total cholesterol: 5.2-7.5 mmol/L)

Exclusion Criteria

Pregnant or lactating women
Individuals on antibiotics or probiotics within the past three months.
Individuals with severe health conditions affecting cholesterol metabolism

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total cholesterol. Timepoint: before trial and six weeks of medication use. Method of measurement: blood sampling.

Secondary Outcome Measures

Name	Time	Method
Blood glucose level. Timepoint: before trial and after 6 weeks of medication use. Method of measurement: blood sampling.